Background Dry eye is a very common eye presentation nowadays due to extensive use of digital devices, so that it was important for us to see the impact of dry eye on corneal topography and wavefront data because it has a strong relation with refractive surgeries. In the past, it was hard to know the effect of dry eye on corneal parameters, but after the new medical technology, it is possible to do that. Aim The aim of the study was to evaluate the effect of dry eye on corneal topography and wavefront data. Patients and methods In total, 40 patients were included in this study with mild and moderate dry eye. Corneal topography and wavefront data were collected before and after treatment with artificial eye drops for 4 weeks. Results Eleven eyes show an increase in peak central corneal thickness after treatment from 1 up to 5 μm. Five eyes show changes in corneal volume after treatment. Eight eyes show a decrease in k1 after treatment. In total, 13 eyes show a decrease in k2 after treatment. Seven eyes show a decrease in root mean square values. Conclusion Dry eye can affect corneal topography increasing the higher order aberrations, so that screening for dry eye is important in the preoperative evaluation of refractive surgery candidates.

No abstract

No abstract

Congenital Diaphragmatic Hernia (CDH) is a rare congenital anomaly characterized by a defect in the diaphragm, which permits abdominal organs to herniate into the thorax. This causes lung hypoplasia and at birth, children with CDH experience respiratory distress and pulmonary hypertension. Despite optimal neonatal treatment, CDH is still associated with a high mortality and morbidity. In severe cases, Fetal Intervention (FETO) may alter the natural course of this disease. Herein we describe the rationale, action mechanism and technique to perform this intervention. Despite hope giving results, this technique remains investigational for left sided CDH. However, an increased survival may come at the cost of increased morbidity. Children born with CDH are at increased risk for long and short-term morbidity, including neurodevelopmental problems. Until now, there are still uncertainties about the severity and prevalence of neurologic morbidity. Furthermore, it remains uncertain if these problems are already present prenatally and if a prenatal intervention influence this.